Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) Net Income - Minority (2018 - 2025)

Addex Therapeutics' Net Income - Minority history spans 8 years, with the latest figure at -$6.0 million for Q4 2025.

  • On a quarterly basis, Net Income - Minority rose 46.01% to -$6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.0 million, a 46.01% increase, with the full-year FY2025 number at -$5.7 million, up 47.95% from a year prior.
  • Net Income - Minority came in at -$6.0 million for Q4 2025, up from -$11.0 million in the prior quarter.
  • The five-year high for Net Income - Minority was -$1.3 million in Q4 2023, with the low at -$18.4 million in Q4 2021.
  • Historically, Net Income - Minority has averaged -$8.4 million across 5 years, with a median of -$6.0 million in 2025.
  • Biggest five-year swings in Net Income - Minority: skyrocketed 74.69% in 2023 and later crashed 755.77% in 2024.
  • Year by year, Net Income - Minority stood at -$18.4 million in 2021, then skyrocketed by 72.23% to -$5.1 million in 2022, then skyrocketed by 74.69% to -$1.3 million in 2023, then tumbled by 755.77% to -$11.0 million in 2024, then soared by 46.01% to -$6.0 million in 2025.
  • Business Quant data shows Net Income - Minority for ADXN at -$6.0 million in Q4 2025, -$11.0 million in Q4 2024, and -$1.3 million in Q4 2023.